http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3867314

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
issn 1465-542X
1465-5411
issueIdentifier 3
pageRange r47-
publicationName Breast cancer research : BCR
startingPage r47
bibliographicCitation Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, Lien E, Feroce I, Pruneri G, Sandri M, Bassi F, Brenelli F, Luini A, Cazzaniga M, Varricchio C, Guerrieri-Gonzaga A, DeCensi A, Bonanni B. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res. 2013 Jun 20;15(3):R47. PMID: 23786776; PMCID: PMC4053157.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc01fcc0137bfca6c3cd7367fb73b30f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fb4e1c7a3ec862342d0717b2fd3a489
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7aeaeb0a75fe1d309866744a35ce74f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f66481eeb619831840122172750b6c49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4437-4237
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a35693aee14c43afd5f3cf589f07520
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b8686cc231751b10170e4c6cfb08a04
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70eb6d3cf29f66e634a0c06b26714135
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5c9179cec40fe12a536c84157a46e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2635-4491
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7963-7172
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dd234bcc8fe4596ac8c9472db336c72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c208726555ffffbf677f3c5868fb179e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2945-4108
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7b913136f3c3b16de3d852b3f8f918e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83882b6ffc169549a5b18bd8d4506412
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_213e59a1fb993f1a3e725ba1a520a5a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fd587593b5e075ed100b1f59c7cfb14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1348-4548
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9312-2020
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4131-2030
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19c97bc7c14dfb2de3ee126535efd0f6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85f6fb7c8d9a4280970a2bf1ce80e715
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2162-4002
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0633-2933
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8853bf75a5966bd9d1254809e6f63c76
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcc7dcd7b6511c98a6e1b860721d8e95
date 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/bcr3439
https://pubmed.ncbi.nlm.nih.gov/23786776
https://pubmed.ncbi.nlm.nih.gov/PMC4053157
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884
https://portal.issn.org/resource/ISSN/1465-5411
https://portal.issn.org/resource/ISSN/1465-542X
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
discusses http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0280632
http://id.nlm.nih.gov/mesh/M0028859
http://id.nlm.nih.gov/mesh/M0016932
http://id.nlm.nih.gov/mesh/M0112969
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e2a00b2f729cd3e914d6490e7348f4c1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f258d559df86a3ecbbb4d5a4da82aa1f
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b972b5d726037ca07d19472a4ac78306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f02b83a26fc01f93e52937e4314d7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5035

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789476

Total number of triples: 66.